Literature DB >> 32068099

Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9th edition.

Pouya Saeedi1, Paraskevi Salpea2, Suvi Karuranga2, Inga Petersohn2, Belma Malanda2, Edward W Gregg3, Nigel Unwin4, Sarah H Wild5, Rhys Williams6.   

Abstract

AIMS: To estimate the number of deaths attributable to diabetes in 20-79-year-old adults in 2019.
METHODS: The following were used to estimate the number of deaths attributable to diabetes: all-cause mortality estimates from the World Health Organization life table, country level age- and sex-specific estimates of diabetes prevalence in 2019 and relative risks of death in people with diabetes compared to people without diabetes.
RESULTS: An estimated 4.2 million deaths among 20-79-year-old adults are attributable to diabetes. Diabetes is estimated to contribute to 11.3% of deaths globally, ranging from 6.8% (lowest) in the Africa Region to 16.2% (highest) in the Middle East and North Africa. About half (46.2%) of deaths attributable to diabetes occur in people under the age of 60 years. The Africa Region has the highest (73.1%) proportion of deaths attributable to diabetes in people under the age of 60 years, while the Europe Region has the lowest (31.4%).
CONCLUSIONS: Diabetes is estimated to contribute to one in nine deaths among adults aged 20-79 years. Prevention of diabetes and its complications is essential, particularly in middle-income countries, where the current impact is estimated to be the largest. Contemporary data from diverse populations are needed to validate these estimates.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  International Diabetes Federation; diabetes; global; mortality; regional

Year:  2020        PMID: 32068099     DOI: 10.1016/j.diabres.2020.108086

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  98 in total

1.  Serum cytokine dependent hematopoietic cell linker (CLNK) as a predictor for the duration of illness in type 2 diabetes mellitus.

Authors:  Suhaer Zeki Al-Fadhel; Nibras H Abdulsada Al-Ghuraibawi; Dunia M Mohammed Ali; Hussein Kadhem Al-Hakeim
Journal:  J Diabetes Metab Disord       Date:  2020-07-17

2.  No pleotropic effects of linagliptin on atherosclerotic plaques: Case closed.

Authors:  Mouaz H Al-Mallah; Fabien Hyafil; Gaetano Santulli
Journal:  Atherosclerosis       Date:  2020-05-28       Impact factor: 5.162

3.  Pulmonary and vascular effects of acute ozone exposure in diabetic rats fed an atherogenic diet.

Authors:  Samantha J Snow; Andres R Henriquez; Leslie C Thompson; Cynthia Fisher; Mette C Schladweiler; Charles E Wood; Urmila P Kodavanti
Journal:  Toxicol Appl Pharmacol       Date:  2021-01-30       Impact factor: 4.219

4.  Peripheral metabolic effects of ozone exposure in healthy and diabetic rats on normal or high-cholesterol diet.

Authors:  Samantha J Snow; Andres R Henriquez; Anna Fisher; Beena Vallanat; John S House; Mette C Schladweiler; Charles E Wood; Urmila P Kodavanti
Journal:  Toxicol Appl Pharmacol       Date:  2021-01-30       Impact factor: 4.219

5.  Associations of midpoint of sleep and night sleep duration with type 2 diabetes mellitus in Chinese rural population: the Henan rural cohort study.

Authors:  Zhihan Zhai; Xiaotian Liu; Haiqing Zhang; Xiaokang Dong; Yaling He; Miaomiao Niu; Mingming Pan; Chongjian Wang; Xiaoqiong Wang; Yuqian Li
Journal:  BMC Public Health       Date:  2021-05-07       Impact factor: 3.295

6.  Factors Associated with Foot Lesions in Diabetic Patients at Saint-Louis Hospital (Senegal): A Case-Control Study Protocol.

Authors:  A Ndong; B Konta; J N Tendeng; D G Dia; A D Dia; M L Diao; A C Diallo; S Diop; B M Gouamba; D A Dia; M Diedhiou; M Dieng; M L Fall; P M Ma Nyemb; I Konaté
Journal:  Int J Surg Protoc       Date:  2021-04-09

Review 7.  Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.

Authors:  Jaime Guevara-Aguirre; Camila Bautista; Carlos Torres; Gabriela Peña; Carolina Guevara; Cristina Palacios; Alexandra Guevara; Antonio W D Gavilanes
Journal:  Rev Endocr Metab Disord       Date:  2020-10-12       Impact factor: 6.514

Review 8.  The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer's disease, type 2 diabetes, and type 2 diabetes-related Alzheimer's disease.

Authors:  Ling He; Yi Sun
Journal:  Metab Brain Dis       Date:  2021-06-15       Impact factor: 3.584

9.  Frailty increases the risk for developing urinary tract infection among 79,887 patients with diabetic mellitus and chronic kidney disease.

Authors:  Chia-Ter Chao; Szu-Ying Lee; Jui Wang; Kuo-Liong Chien; Jenq-Wen Huang
Journal:  BMC Geriatr       Date:  2021-06-07       Impact factor: 3.921

10.  Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial.

Authors:  Eun-Young Lee; Jae-Seung Yun; Seon-Ah Cha; Sun-Young Lim; Jin-Hee Lee; Yu-Bae Ahn; Kun-Ho Yoon; Seung-Hyun Ko
Journal:  Int J Environ Res Public Health       Date:  2021-05-16       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.